EP1328151A4 - Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer - Google Patents

Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer

Info

Publication number
EP1328151A4
EP1328151A4 EP00953630A EP00953630A EP1328151A4 EP 1328151 A4 EP1328151 A4 EP 1328151A4 EP 00953630 A EP00953630 A EP 00953630A EP 00953630 A EP00953630 A EP 00953630A EP 1328151 A4 EP1328151 A4 EP 1328151A4
Authority
EP
European Patent Office
Prior art keywords
hyde
cancer
induction
methods
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00953630A
Other languages
German (de)
French (fr)
Other versions
EP1328151A2 (en
Inventor
Mitchell S Steiner
Chiang Wang
Augustinus Rinaldy
Rema Menon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tennessee Research Foundation
Original Assignee
University of Tennessee Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US30245799A priority Critical
Priority to US13160799P priority
Priority to US302457 priority
Priority to US131607P priority
Priority to US499817 priority
Priority to US09/499,817 priority patent/US7043009B1/en
Application filed by University of Tennessee Research Foundation filed Critical University of Tennessee Research Foundation
Priority to PCT/US2000/011456 priority patent/WO2000071564A2/en
Publication of EP1328151A2 publication Critical patent/EP1328151A2/en
Publication of EP1328151A4 publication Critical patent/EP1328151A4/en
Application status is Withdrawn legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747Apoptosis related proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
EP00953630A 1999-04-29 2000-05-01 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer Withdrawn EP1328151A4 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US30245799A true 1999-04-29 1999-04-29
US13160799P true 1999-04-29 1999-04-29
US302457 1999-04-29
US131607P 1999-04-29
US09/499,817 US7043009B1 (en) 2000-02-08 2000-02-08 Providing customer data to an automatic call distribution system agent
US499817 2000-02-08
PCT/US2000/011456 WO2000071564A2 (en) 1999-04-29 2000-05-01 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer

Publications (2)

Publication Number Publication Date
EP1328151A2 EP1328151A2 (en) 2003-07-23
EP1328151A4 true EP1328151A4 (en) 2004-06-16

Family

ID=27384176

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00953630A Withdrawn EP1328151A4 (en) 1999-04-29 2000-05-01 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer

Country Status (5)

Country Link
EP (1) EP1328151A4 (en)
JP (1) JP2003529321A (en)
AU (1) AU769889B2 (en)
CA (1) CA2371828A1 (en)
WO (1) WO2000071564A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835812B1 (en) * 1999-04-29 2004-12-28 University Of Tennessee Research Corporation Human p-Hyde proteins

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use
WO2001059127A2 (en) * 2000-02-11 2001-08-16 Incyte Genomics, Inc. Drug metabolizing enzymes
WO2001072962A2 (en) * 2000-03-24 2001-10-04 Fahri Saatcioglu Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT307886T (en) * 1995-12-20 2005-11-15 Cerenis Nucleotide sequences, proteins, medicaments and diagnosis agents for the use of cancer treatment

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use
WO2001059127A2 (en) * 2000-02-11 2001-08-16 Incyte Genomics, Inc. Drug metabolizing enzymes
WO2001072962A2 (en) * 2000-03-24 2001-10-04 Fahri Saatcioglu Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
AMSON R B ET AL: "ISOLATION OF 10 DIFFERENTIALLY EXPRESSED CNDAS IN P53-INDUCED APOPTOSIS: ACTIVATION OF THE VERTEBRATE HOMOLOGUE OF THE DROSOPHILA SEVEN IN ABSENTIA GENE", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 9, 30 April 1996 (1996-04-30), pages 3953 - 3957, XP002032914, ISSN: 0027-8424 *
DATABASE EMBL [online] EBI; 22 February 2000 (2000-02-22), "Homo sapiens cDNA FLJ10829 fis, clone NT2RP4001138", XP002276044, retrieved from EMBL Database accession no. AK001691 *
RINALDY A R ET AL: "Role of pHyde novel gene product as an intrinsic factor for apoptotic pathway in prostate cancer.", GAN TO KAGAKU RYOHO. CANCER & CHEMOTHERAPY. JAPAN MAY 2000, vol. 27 Suppl 2, May 2000 (2000-05-01), pages 215 - 222, XP009028708, ISSN: 0385-0684 *
See also references of WO0071564A3 *
STEINER M S ET AL: "GROWTH INHIBITION OF PROSTATE CANCER BY AN ADENOVIRUS EXPRESSING A NOVEL TUMOR SUPPRESSOR GENE, PHYDE", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, vol. 60, no. 16, 15 August 2000 (2000-08-15), pages 4419 - 4425, XP001076638, ISSN: 0008-5472 *
ZHANG X ET AL: "APOPTOSIS INDUCTION IN PROSTATE CANCER CELLS BY A NOVEL GENE PRODUCT, PHYDE, INVOLVES CASPASE-3", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 20, no. 42, 20 September 2001 (2001-09-20), pages 5982 - 5990, XP008003138, ISSN: 0950-9232 *

Also Published As

Publication number Publication date
AU6604600A (en) 2000-12-12
WO2000071564A2 (en) 2000-11-30
WO2000071564A3 (en) 2003-05-01
AU769889B2 (en) 2004-02-05
EP1328151A2 (en) 2003-07-23
JP2003529321A (en) 2003-10-07
CA2371828A1 (en) 2000-11-30
WO2000071564A8 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
DE69942639D1 (en) Use of paramagnetic material for purification and manipulation of nucleic acids
DE69938653D1 (en) Isolated cells for use in the treatment of diseases of the central nervous system
DE60031007D1 (en) Selection of binding regions for zinc finger proteins and design methods for zinc finger proteins suitable for binding to such preselected regions
DE69632466D1 (en) Solution the chaotropic agent contains and use of this solution in methods for isolating dna, rna and proteins
DK2088188T3 (en) Direct expression of peptides in culture media
DE69837393D1 (en) Stimulation of hematopoietic cells in the vitro
DK0983342T3 (en) Culture medium with soybean extract as amino acid source and no animal complexes of animal origin
DK1129190T3 (en) Human TSLP DNA and Polypeptides
DK1200384T3 (en) 2-Alkyl-5-halo-pent-4-encarboxylic acids and their preparation
DE69922937D1 (en) Lactobacilli containing aggregates and mucin-binding genes as vaccines trailers
DE69925618D1 (en) Rna cancer vaccine and method of use thereof
DE60031489D1 (en) Universal samples and methods for the detection of nucleic acids
DE69824039D1 (en) Heterodimary fusion proteins for use in targeted immunotherapy and general immune stimulation
DK1158866T3 (en) Use of antifreeze proteins in ice-cream products
DE60039291D1 (en) Camptothecinanaloges and their preparation methods
DK1005540T3 (en) IKK-beta proteins, nucleic acids and methods
AU3869400A (en) Human cancer associated gene sequences and polypeptides
DE60032226D1 (en) Method for the induction of cancer cell and tumor regression
DK1508620T3 (en) Circular DNA molecule with conditional origin of replication, methods for its preparation and use in gene therapy
HU0201474A3 (en) Expression and export of interferon-alpha proteins as fc fusion proteins
AP200001762A0 (en) Method of delivering genes to antigen presenting cells of the skin
PT652705E (en) Nucleic acids and methods for their use in combating viral pathogens
EP0275957A3 (en) Plant-functional phosphinothricin resistance gene and its use
DE122007000070I1 (en) In Vitro Reconstitution of Segmented Negative Strand Rna Viruses
AT486957T (en) DNA βTYPINGβ WITH SHORT TANDEM-REPETITIVE POLIMORPHISMS AND IDENTIFICATION OF SHORT POLYMPHONES TANDEM REPEATS

Legal Events

Date Code Title Description
AX Request for extension of the european patent to

Countries concerned: ALLTLVMKROSI

17P Request for examination filed

Effective date: 20011112

AK Designated contracting states:

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Classification (correction)

Ipc: 7C 07K 16/30 B

Ipc: 7A 61K 31/7052 B

Ipc: 7C 07K 16/00 B

Ipc: 7C 07K 14/47 B

Ipc: 7C 12N 15/12 B

Ipc: 7G 01N 33/574 B

Ipc: 7C 12P 21/00 B

Ipc: 7C 12N 15/62 A

Ipc: 7C 12N 15/861 B

Ipc: 7C 12Q 1/70 B

Ipc: 7A 61K 48/00 B

Ipc: 7C 07H 21/00 B

Ipc: 7A 01K 67/027 B

Ipc: 7A 61P 35/00 B

Ipc: 7C 07K 19/00 B

A4 Despatch of supplementary search report

Effective date: 20040504

RAP1 Transfer of rights of an ep published application

Owner name: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION

18D Deemed to be withdrawn

Effective date: 20080411